What does a dengue panel with negative dengue NS1 antigen (non-structural protein 1), positive immunoglobulin G (IgG), and negative immunoglobulin M (IgM) indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Interpretation of Dengue NS1 Negative, IgG Positive, IgM Negative

This serologic pattern indicates a past dengue infection, not an acute or recent infection, and the patient's current symptoms are unlikely to be caused by dengue. 1

Understanding the Test Results

The combination of negative NS1, positive IgG, and negative IgM has a specific meaning in the timeline of dengue infection:

  • IgG antibodies persist for months to years after dengue infection, so their presence alone confirms only prior exposure, not active disease. 1

  • IgM antibodies typically appear 3-5 days after symptom onset and can persist for 2-3 months following the initial infection. 1 The absence of IgM makes a recent infection (within the past 2-3 months) highly unlikely. 1

  • NS1 antigen is detectable from day 1 through day 10 of illness, with peak sensitivity during days 1-5. 1 A negative NS1 in the acute phase (≤7 days) effectively rules out active viral replication. 1

Clinical Interpretation Algorithm

For specimens collected ≤7 days after symptom onset:

  • Negative NS1 combined with negative IgM and positive IgG indicates the patient had dengue in the past but does not have acute dengue now. 2, 1
  • The positive IgG represents immunologic memory from a previous infection (months to years ago). 1

For specimens collected >7 days after symptom onset:

  • This pattern still indicates past infection rather than current disease, because IgM would be expected to be positive in any recent infection during this window. 1, 3
  • A negative IgM result collected 7 days to 12 weeks after symptom onset rules out recent dengue infection. 1

Required Next Steps

  • Do not perform confirmatory PRNT testing for this serologic pattern, as it is not indicated when both NS1 and IgM are negative. 2, 1 PRNT is reserved for cases with positive IgM to distinguish dengue from other flavivirus infections. 2

  • Investigate alternative diagnoses to explain the patient's current symptoms, as dengue has been effectively excluded. 2, 3

  • Consider testing for other febrile illnesses endemic to the region of exposure, including malaria (perform rapid malaria test first in travelers from endemic regions), chikungunya, Zika virus, leptospirosis, and other flaviviruses. 4, 3

Common Pitfalls to Avoid

  • Do not assume acute infection based on positive IgG alone, as IgG can persist indefinitely after the initial infection and does not indicate timing. 1

  • Do not repeat dengue serologic testing in this scenario, as the negative IgM already rules out recent infection when collected in the appropriate time window. 1, 3

  • Do not misinterpret this as "indeterminate"—this is a definitive result indicating past, not current, dengue infection. 1, 3

  • Be aware that previous flavivirus vaccination or infection (yellow fever, Japanese encephalitis, Zika) can cause positive IgG due to cross-reactivity, but this does not change the clinical interpretation that acute dengue is ruled out. 1, 4

Clinical Context

  • If the patient is currently febrile with dengue-compatible symptoms (headache, retro-orbital pain, myalgia, arthralgia, rash), these symptoms are caused by something other than dengue. 4, 3

  • Document complete vaccination history for yellow fever, Japanese encephalitis, and other flavivirus vaccines, as these can produce positive IgG through cross-reactivity. 1, 4

  • In dengue-endemic areas, this serologic pattern is common in the general population due to high background seroprevalence and does not require any dengue-specific management. 3

References

Guideline

Dengue Infection Diagnosis and Antibody Development

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosis of Dengue in the Post-Acute Phase

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Dengue Fever Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.